VASCULAR MALFORMATIONS
Clinical trials for VASCULAR MALFORMATIONS explained in plain language.
Never miss a new study
Get alerted when new VASCULAR MALFORMATIONS trials appear
Sign up with your email to follow new studies for VASCULAR MALFORMATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for rare blood vessel disorder?
Disease control Recruiting nowThis study tests the drug everolimus in 10 adults with abnormal blood vessels (vascular malformations). The goal is to see if the drug can shrink these vessels and lower the risk of bleeding. Participants take the drug by mouth and have regular MRI scans to check progress.
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New drug targets root cause of rare overgrowth diseases in kids and adults
Disease control Recruiting nowThis study tests a new drug, RLY-2608, designed to block a faulty protein that causes abnormal growth in people with PIK3CA-related overgrowth spectrum (PROS) and related malformations. The trial enrolls 277 adults and children to see if the drug can safely shrink overgrown tissu…
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New hope for rare blood vessel disorders: targeted drugs enter trial
Disease control Recruiting nowThis study tests two targeted drugs for people with abnormal blood vessels (vascular malformations). One drug, alpelisib, is for slow-flow types; the other, mirdametinib, is for fast-flow types. About 50 participants aged 2 and older will take the drug for 48 weeks to see if thei…
Matched conditions: VASCULAR MALFORMATIONS
Phase: PHASE2 • Sponsor: Murdoch Childrens Research Institute • Aim: Disease control
Last updated May 12, 2026 13:41 UTC